The O-Shot: Mechanism and Patient Selection

The O-Shot is one of the most over-marketed and under-explained treatments in sexual wellness. The marketing makes promises the procedure cannot keep on its own, and the explanations rarely tell patients what is actually happening biologically or, more importantly, who the procedure works for and who it does not. I want to take it apart honestly. What it is, what it does, what the evidence supports, and how I decide whether the patient sitting in front of me is a good candidate.

The patients who come to me asking about the O-Shot usually fall into one of three groups. Group one: women in perimenopause or postmenopause whose sexual function has changed — reduced sensation, slower or absent orgasm, vaginal dryness, dyspareunia, urinary urgency or stress incontinence — and who are looking for something other than a daily medication. Group two: women with documented stress urinary incontinence who want to avoid surgery. Group three: women who have read marketing material and are not entirely sure what they are asking for. The first two groups often benefit. The third group benefits from a real conversation about what is actually going on first.

What the O-Shot actually is

Procedurally, the O-Shot is platelet-rich plasma (PRP) injected into specific areas of the vulvovaginal tissue — primarily the periurethral area and the anterior vaginal wall, including the area associated with the clitoral complex. The blood is drawn at the appointment, spun in a centrifuge to concentrate the platelets, and injected after topical and local anesthetic. The procedure itself takes about 30 to 45 minutes and most patients describe it as more pressure than pain.

PRP is the biologic. Platelets are not just clotting cells; they are loaded with growth factors — PDGF (platelet-derived growth factor), VEGF (vascular endothelial growth factor), TGF-beta (transforming growth factor), EGF (epidermal growth factor), and others. When concentrated PRP is delivered into a tissue bed, those growth factors trigger a localized regenerative response: increased angiogenesis (new small blood vessel formation), stem cell recruitment, collagen and elastin remodeling, and neurogenesis at sensory nerve endings.

That is the mechanism. New microvasculature improves tissue perfusion. Collagen remodeling improves tissue turgor and elasticity. Neural sprouting can improve sensitivity. Together, those changes can translate into clinical improvements in arousal, lubrication, sensation, orgasmic function, and urinary continence in the right patient.

Notice the phrase "in the right patient." That is where most of the disappointment with this procedure comes from — patients who were not the right candidates getting the procedure anyway because nobody actually evaluated them first.

What I look for when I evaluate a patient for the O-Shot

When a patient sits down for a sexual wellness consultation in my practice, the procedure is rarely the first thing we talk about. I am working through a list of contributors that almost always overlap, because female sexual dysfunction is rarely caused by one thing.

• Hormonal status. This is the first thing I check, and the most common driver of the symptoms patients are bringing to me. Declining estradiol thins vulvovaginal tissue, reduces lubrication, and lowers sensitivity. Declining testosterone (yes, women have it and yes, it matters) reduces libido and arousal. Low DHEA reduces local tissue androgen production. A woman with low estradiol getting an O-Shot without addressing her hormones is going to get a partial result at best, because the underlying tissue is still hormone-deprived. Hormone optimization is often a prerequisite, not an alternative.
• Vaginal tissue exam findings. Atrophic, pale, thinned tissue tells me a different story than well-estrogenized tissue with a specific localized issue. The exam guides whether the right answer is hormonal first, regenerative first, or both in parallel.
• Pelvic floor function. Hypertonic pelvic floor muscles, prior obstetric trauma, pudendal nerve issues — none of these respond to PRP. They respond to pelvic floor physical therapy, sometimes with adjunct interventions. Missing this and recommending an O-Shot wastes the patient's money.
• Medication review. SSRIs, SNRIs, beta-blockers, certain antihistamines, hormonal contraceptives, and several blood pressure medications can all reduce arousal, sensation, or orgasmic function. A patient on a high-dose SSRI for ten years has a pharmacological problem the O-Shot is not going to override.
• Vascular and metabolic health. Sexual function in mid-life is partly a vascular issue. Insulin resistance, hypertension, lipid disorders, and early atherosclerotic disease all affect microvascular perfusion in pelvic tissues. The patient with poor metabolic health and poor sexual function often needs the metabolic work in parallel.
• Psychological and relational factors. I am not a therapist and I do not pretend to be. But I have learned to ask the question, because a patient whose primary issue is anxiety, depression, trauma history, or relationship distress needs a different referral, not a procedure. Doing the procedure on her anyway will not address what is actually wrong.
• Stress urinary incontinence specifically. This is one of the indications where the O-Shot has the most consistent published support. A woman with mild-to-moderate stress incontinence — leakage with coughing, sneezing, jumping, exercise — who is not yet a surgical candidate often does very well with PRP delivered to the periurethral tissue. This is one of the most reliable use cases.

After 17 years in clinical medicine — emergency department, cardiac ICU, cath lab, and now hormone and regenerative work — the consistent lesson is that the workup determines the outcome. The O-Shot is a good tool for the right patient. It is the wrong answer for a patient whose problem is hormonal, neurological, vascular, pharmacological, pelvic-floor, or psychological.

The mechanism of why it works (when it works)

The clinical effects patients report — improved sensation, more reliable orgasm, less dryness, less urinary leakage — map back to the tissue-level changes PRP triggers over six to twelve weeks. The clitoral complex is highly vascular and highly innervated, and PRP-driven angiogenesis and neurogenesis in this area can meaningfully change function in a patient whose baseline tissue still has the capacity to respond.

The periurethral injection works through a different mechanism — collagen and connective tissue remodeling that increases the structural support of the urethra. Stress incontinence is fundamentally a problem of the urethra losing its mechanical support during increases in abdominal pressure. PRP-mediated tissue strengthening in this area is why the incontinence indication has held up well in published series.

The timeline is consistent across mechanisms. Initial tissue response in the first two to four weeks. Noticeable functional change at six to eight weeks. Full effect at about twelve weeks. A single treatment can hold for nine to fifteen months in a good responder. Some patients do better with a series of two treatments spaced eight to twelve weeks apart, particularly if the baseline tissue is more atrophic.

Who I tell to wait, and what I tell them to do first

I send a meaningful percentage of patients out of the sexual wellness consultation without booking an O-Shot. The conversation is straightforward and I would rather have it than do an unnecessary procedure.

• Patient with significant vaginal atrophy and no current hormone therapy. First step is hormone evaluation and probably topical or systemic estrogen. We can revisit the O-Shot at three months if symptoms persist, but tissue that is hormone-starved does not respond well to regenerative treatment and we are wasting the procedure if we do it first.
• Patient on an SSRI with sexual side effects as the chief complaint. First step is a conversation with the prescriber about whether the medication can be adjusted, switched, or augmented. Sometimes it can; sometimes it cannot, but the conversation has to happen first.
• Patient with primary pelvic pain. This needs a workup before any injection. Pelvic floor physical therapy, sometimes a pelvic medicine referral, sometimes both. Injecting PRP into a pelvic pain syndrome is not the answer.
• Patient whose underlying issue is psychological or relational. A respectful referral to a sex-positive therapist is the right next step, not a procedure.

This is also where the conversation with male partners sometimes opens up. If a heterosexual couple is dealing with sexual difficulties on both sides, addressing only one half of the equation rarely produces a good result. We do not treat couples together in this practice, but we do treat both partners — men's hormone therapy and ED treatment for the male partner often runs in parallel with the female partner's workup, and that combined approach is usually more effective than either patient working on their own.

Realistic expectations

The patients who come back to me happiest at three and six months had realistic expectations going in. The procedure is meaningful. It is not transformative on its own. It is a piece of a plan, and the plan is what produces the durable change. A patient who arrived expecting a single shot to restore the sexual function she had at 32 is going to be disappointed. A patient who arrived understanding that the O-Shot is one component of a coordinated approach — hormones, tissue health, partner factors, lifestyle, sometimes medication adjustments — is the one who tells me at her three-month follow-up that things are noticeably better.

I also tell patients at the first visit that not everything works for everyone. A small percentage of patients do not respond meaningfully to PRP. We track response at the eight to twelve week mark and have an honest conversation if the result is not what either of us hoped for. Sometimes a second treatment is the right answer. Sometimes the conclusion is that we need to look harder at the contributors we have not addressed yet. Either way, we do not pretend a result happened that did not.

Your next step

If you have been thinking about the O-Shot, the comprehensive workup is the place to start. Book a private consultation at either the Columbus consultation or the Warner Robins location — same protocol at both, and the appointment itself is private, professional, and focused on actually solving the problem rather than selling you a procedure. Bring whatever recent labs you have and a list of medications. The conversation we have will tell us whether the O-Shot is the right tool for your situation, what other pieces need to be addressed first or in parallel, and what realistic outcomes look like for your specific picture.

*Information in this article is educational and does not constitute medical advice. Sexual wellness recommendations require an in-person consultation. Individual results vary.*

TW

Travis Woodley

MSN, RN, CRNP — Platinum Biote Provider — Founder, Revitalize

Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.

About Travis →More articles →Rebuild Institute →